Axcan Pharma Inc.

Axcan Pharma Inc.

May 01, 2007 12:00 ET

Axcan Announces Conference Call and Webcast for Second Quarter of Fiscal 2007 Results

MONT-SAINT-HILAIRE, QUEBEC--(CCNMatthews - May 1, 2007) - Axcan Pharma Inc. (TSX:AXP)(NASDAQ:AXCA) ("Axcan" or the "Company") today announced that it will report financial results for the second quarter of fiscal 2007, ended March 31, 2007, on Thursday, May 10, 2007, after market close.

Axcan will host a conference call at 8:30 A.M. ET, on Friday, May 11, 2007. Interested parties may also access the conference call by webcast at The webcast will be archived for 90 days.

The telephone numbers to access the conference call are (800) 595-8550 (Canada and United States) or (416) 644-3427 (international). A replay of the call will be available until May 18, 2007. The telephone numbers to access the replay of the call are (877) 289-8525 or (416) 640-1917, passcode 21228653#.

About Axcan Pharma

Axcan is a leading multinational specialty pharmaceutical company focused on gastroenterology. The company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and Europe. Its common shares are listed on the NASDAQ Global Market under the symbol "AXCA" and on the Toronto Stock Exchange under the symbol "AXP".

Contact Information

  • Axcan Pharma Inc.
    Isabelle Adjahi
    Senior Director, Investor Relations and Communications
    450-467-2600 ext. 2000